Yan Lin

Yan Lin

Auto-generated profile, based on publicly available information

Yan Lin

School of Life Sciences Zhengzhou University Zhengzhou 450001 China zzu.edu.cn

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2021 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
YLYan Lin
Yan Lin
YDYu Dong
Yu Dong
YGYANFENG GAO
YANFENG GAO
RSRanran Shi
Ranran Shi
YLYubing Li
Yubing Li
YWYahong Wu
Yahong Wu
Tuberculosis is the worlds most deadly infectious disease, with 10 million people falling ill and 1.5 million people dying from the disease every year. With the increasing number of drug-resistant Mycobacterium tuberculosis (MTB) strains and prevalence of coinfection of MTB with human immunodeficiency virus, many challenges remain in the prevention and treatment of tuberculosis. Therefore, the development of safe and effective tuberculosis vaccines is an urgent issue. In this study, we identified cytotoxic T lymphocyte epitopes on drug resistance-associated membrane protein efflux pumps of MTB, the ATP-binding cassette and the major facilitator superfamilies. First, three online software were used to predict HLA-A2-restricted epitopes. Then, the candidate epitopes were confirmed with the T2A2 cell binding affinity and peptide/MHC (pMHC) complex stability assays and in vitro immune activity experiments. Two drug-resistant T lymphocyte epitopes, designated Rv1218c-p24 and Rv2477c-p182, were selected, and their immunogenic activities studied in vivo in genetically engineered mice. The immune activities of these two epitopes were improved with the help of complete Freunds adjuvant (CFA). The epitopes identified here provide a foundation for the diagnosis and treatment of patients infected with drug resistant and the future development of a multiepitope vaccine.

1 February 2013 in Journal of Virological Methods
Verified
Journal Article
Closed access
WZWeijun Zhang
Weijun Zhang
XLXuemei Li
Xuemei Li
YLYan Lin
Yan Lin
DTDonghua Tian
Donghua Tian